Patrick A Cosgrove

8PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 27, 2026
A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind.

Rena Emond, Jeffrey West, Vince K Grolmusz

|May 09, 2025
Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer.

Jason I Griffiths, Feng Chi, Elena Farmaki

|Mar 03, 2025
Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers.

Jason I Griffiths, Patrick A Cosgrove, Eric F Medina

|Jan 08, 2025
Single-Cell Transcriptomics Sheds Light on Tumor Evolution: Perspectives from City of Hope's Clinical Trial Teams.

Patrick A Cosgrove, Andrea H Bild, Thanh H Dellinger

|Sep 29, 2023
ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer.

Elena Farmaki, Aritro Nath, Rena Emond

|Oct 29, 2021
Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy.

Jason I Griffiths, Jinfeng Chen, Patrick A Cosgrove

Pageof 2

Frequent Collaborators

4 joint publications

Jeffrey T Chang

3 joint publications

Jason I Griffiths

3 joint publications

Aritro Nath

3 joint publications

Andrea H Bild